Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

696
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
696
What is the Immune System?01:38

What is the Immune System?

127.0K
Overview
127.0K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

2.1K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.1K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

802
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
802
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

3.3K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.3K
Gene Therapy00:59

Gene Therapy

27.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Newborn screening reduces survival disparities in SCID after stem cell transplant: A PIDTC report.

Journal of human immunity·2026
Same author

Primary Immune Regulatory Disorders (PIRD): Tools for Diagnosis and Disease Activity Assessment to Guide Therapy.

The journal of allergy and clinical immunology. In practice·2026
Same author

Minimal Residual Disease by High-Throughput Sequencing in Standard Risk-Favorable Pediatric B-Lymphoblastic Leukemia.

Blood advances·2026
Same author

Hematopoietic Stem Cell Transplant for JAK-STAT Disorders.

The journal of allergy and clinical immunology. In practice·2026
Same author

High-resolution single-cell mapping of clonal hematopoiesis and structural variation in aplastic anemia.

Nature genetics·2026
Same author

Genomic Subtype Influences BH3 Mimetic Drug Sensitivity and Synergy with Cytotoxic Chemotherapeutics in T-cell Acute Lymphoblastic Leukemia.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Related Experiment Video

Updated: Jan 21, 2026

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

4.4K

Cellular therapy: Immune-related complications.

Joseph H Oved1, David M Barrett1, David T Teachey1

  • 1Divisions of Hematology and Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.

Immunological Reviews
|July 30, 2019
PubMed
Summary

Chimeric antigen receptor T-cell (CAR-T) therapy offers a revolutionary treatment for leukemia and lymphoma but can cause cytokine release syndrome (CRS) and neurotoxicity. Personalized management strategies are crucial for addressing these unique side effects.

Keywords:
CAR-TCREScell therapycytokine release syndromeimmunotherapy

More Related Videos

Multicolor Flow Cytometry Analyses of Cellular Immune Response in Rhesus Macaques
07:11

Multicolor Flow Cytometry Analyses of Cellular Immune Response in Rhesus Macaques

Published on: April 22, 2010

21.7K
Surgical Closure of Equine Abdomen, Prevention, and Management of Incisional Complications
09:41

Surgical Closure of Equine Abdomen, Prevention, and Management of Incisional Complications

Published on: May 10, 2024

1.7K

Related Experiment Videos

Last Updated: Jan 21, 2026

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

4.4K
Multicolor Flow Cytometry Analyses of Cellular Immune Response in Rhesus Macaques
07:11

Multicolor Flow Cytometry Analyses of Cellular Immune Response in Rhesus Macaques

Published on: April 22, 2010

21.7K
Surgical Closure of Equine Abdomen, Prevention, and Management of Incisional Complications
09:41

Surgical Closure of Equine Abdomen, Prevention, and Management of Incisional Complications

Published on: May 10, 2024

1.7K

Area of Science:

  • Immunotherapy
  • Oncology
  • Hematology

Background:

  • Chimeric antigen receptor T-cell (CAR-T) therapy represents a significant advancement in treating relapsed/refractory leukemia and lymphoma.
  • While highly effective, CAR-T therapy is associated with unique toxicities, including cytokine release syndrome (CRS) and neurotoxicity.

Purpose of the Study:

  • To review the mechanistic contributions to CAR-T-related CRS and neurotoxicity.
  • To discuss the impact of CAR-T constructs, tumor type, and patient factors on toxicity development.
  • To highlight the need for personalized approaches in managing CAR-T therapy side effects.

Main Methods:

  • Literature review of recent studies on CAR-T therapy mechanisms and side effects.
  • Analysis of factors influencing the development and severity of CRS and neurotoxicity.
  • Discussion of current and potential therapeutic interventions.

Main Results:

  • Cytokine release syndrome (CRS) results from overwhelming cytokine release by activated immune cells, sharing similarities with systemic inflammatory response syndrome and macrophage activating syndrome.
  • Tocilizumab is FDA-approved for CRS but not universally effective, necessitating further therapeutic options.
  • CAR-T-related neurotoxicity's pathophysiology is not fully understood, limiting current treatment to supportive care, though research is advancing.

Conclusions:

  • Understanding the intrinsic factors of CAR-T constructs, tumor characteristics, and patient-specific elements is key to managing CRS and neurotoxicity.
  • Personalized medicine approaches are essential for effectively managing the unique side effects associated with CAR-T and cellular therapies.